Memorial Hospital of Carbondale — Biomedical Watch V2

Essais liés8clinical trials

VilleCarbondalelocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03984448

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
Biospecimen Collection	Cancer	Phase 3	NCT07097142	Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study	RECRUITING
Cilostazol 100 mg Tablets	Accident vasculaire cérébral	Phase 3	NCT07174414	Clarity — Cilostazol for Prevention of Recurrent Stroke Trial	NOT_YET_RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT04269902	Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study	RECRUITING
Biospecimen Collection	SEP	Phase 2/3	NCT03984448	Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas	ACTIVE_NOT_RECRUITING
Biopsy Procedure	SEP	Phase 2	NCT02143414	Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia	ACTIVE_NOT_RECRUITING
Acalabrutinib	Cancer	Phase 2	NCT04115631	A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma	ACTIVE_NOT_RECRUITING
Biopsy Procedure	Cancer	Phase 2/3	NCT04628767	Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer	RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT04267848	Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])	RECRUITING